Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 307.19B |
| Enterprise Value | 469.4B |
| P/E Ratio | 10.97 |
| PEG Ratio | -0.52 |
| Price/Sales Ratio | 0.13 |
| Price/Book Ratio | 0.43 |
| Enterprise/Revenue | 0.26 |
| Enterprise/EBITDA | 7.99 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 1.66T |
| Revenue/Share | 34,086.35 |
| Gross Profit | 293.22B |
| EBITDA | 48.54B |
| Net Income | 20.97B |
| Diluted EPS | 521 |
Balance Sheet
| Total Cash | 182.71B |
| Total Cash/Share | 3,679.1 |
| Total Debt | 301.19B |
| Total Debt/Equity | 0.47 |
| Current Ratio | 1.3 |
| Book Value Per Share | 14,404.1 |
Price History
| 52-Week Change | -2.92 |
| 52-Week High | 12,800 |
| 52-Week Low | 5,500 |
| Moving Average 50 Days | 7,477.4 |
| Moving Average 200 Days | 6,800.25 |
Statistics
| Average Volume | 250,850 |
| Shares Outstanding | 40.24M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 100 |
| Trailing Annual Dividend Yield | 1.77 |
| Payout Ratio | 0.18 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
